CTHRC1 and pancreatic neoplasm: Finally, to further explore and verify that CTHRC1 in CAFs activates the STAT3 signaling pathway in pancreatic cancer cells by regulating LIF, we cocultured CAFs‐CM with pancreatic cancer cells and added the LIF inhibitor EC330 at various concentrations.